HomeCompaniesProfile

Actipulse Neuroscience

Bringing non-invasive brain stimulation from the hospital to the home 


Company Size

11 - 50 employees

Year Founded

2017


About Actipulse Neuroscience

Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application.

Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment.

Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.

Founders & Key People

Gabriel Villafuerte

Gabriel Villafuerte

Founder, Actipulse Neuroscience

Adrien Châtillon

Adrien Châtillon

Founder, Actipulse Neuroscience

Share This Profile

More Companies

Blitz

Lovable for non-tech users: Build no-code internal and customer apps

Passenger AI

Software for robotaxi operations.

Nourish

Telehealth dietitians covered by insurance

Waydev

The AI Engineering Intelligence Platform | DORA, SPACE, DX, CORE 4

AirMyne

Building systems to remove carbon dioxide from air at industrial scale

Commissary Club

First agentic AI-powered community for 1 billion people with criminal…

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2026 BEAMSTART. All Rights Reserved.